Andrew Hessel is a futurist and catalyst in biological
technologies, helping industry, academics, and authorities
better understand the changes ahead in life science. He is a
Distinguished Researcher with Autodesk Inc. Bio/Nano
Programmable Matter group, based out of San Francisco. He is
also the co-founder of the Pink Army Cooperative, the world
first cooperative biotechnology company, which is aiming to make
open source viral therapies for cancer. Trained in microbiology
and genetics, Andrew has continually worked at the forefront of
genomics, first to read and comprehend bacterial, human, and
other genomes and more recently to write them. He believes the
technology that makes this possible, called synthetic biology,
is revolutionary and that it will eventually surpass information
technology (IT) as an economic engine and driver of societal
change. He speaks widely on topics that include cells as living
computers, life science as an emerging IT industry, and
biological safety and security. Andrew is an advocate of open
genetic engineering, believing that the field will increasingly
resemble the software industry and give rise to open source,
single purpose (app), and freemium applications, and that it
will be spearheaded by younger programmer-entrepreneurs. He is
active in the iGEM and DIYbio (do-it-yourself) communities and
frequently works with students and young entrepreneurs to help
them be successful. Since 2009, Andrew has also been the
co-chair of Bioinformatics and Biotechnology at the Singularity
University, located at the NASA Research Park in Mountain View,
California. There, he educates graduate students and executive
participants on the disruptive shifts underway in life science
and helps them become actively engaged in these changes. In
November, 2011, he was appointed a fellow at the University of
Ottawa, Institute for Science, Society, and Policy, focusing on
how next-generation technologies shape society future. Andrew
has given dozens of invited talks related to synthetic biology,
for groups that include Autodesk Inc., the FBI, the United
Nations Biological Weapons Convention Implementation Support
Unit, TEDx, Intel Inc., the New America Foundation, Alberta
Innovates Technology Futures, the Oil Sands Leadership
Initiative, and Statoil.
Curages Conference
Management GmbH
Schönhauser Allee 10/11
D-10119 Berlin, Germany
www.curages.com
Twitter: @SUGermanySummit